We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

136 hedge funds and large institutions have $338M invested in Sanofi Contingent Value Rights in 2013 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 35 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more capital invested

Capital invested by funds: $324M → $338M (+$13.8M)

7% less funds holding

Funds holding: 146 → 136 (-10)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

40% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 35

59% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 17

Holders
136
Holders Change
-10
Holders Change %
-6.85%
% of All Funds
4.41%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.13%
New
7
Increased
21
Reduced
35
Closed
17
Calls
$1.01M
Puts
–
Net Calls
+$1.01M
Net Calls Change
+$1.01M

Top Buyers

Rank Fund Capital Flow
1
FTCM
Fir Tree Capital Management
New York
+$6.72M
2
MCM
Mason Capital Management
New York
+$5.99M
3
WA
Whitebox Advisors
Minnesota
+$2.25M
4
DI
Dalton Investments
Nevada
+$1.24M
5
SC
Sophrosyne Capital
New York
+$1.09M

Top Sellers

Rank Fund Capital Flow
1
TCA
Taconic Capital Advisors
New York
-$5.79M
2
RCM
Royal Capital Management
New York
-$3.55M
3
FCM
Farallon Capital Management
California
-$2.51M
4
BlackRock
BlackRock
New York
-$2.27M
5
PCM
Pentwater Capital Management
Florida
-$1.69M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1
Abrams Capital Management
Massachusetts
$63M -$170K -89,450 -0.3%
DI
2
Dalton Investments
Nevada
$34M +$1.24M +648,723 +4%
WA
3
Whitebox Advisors
Minnesota
$33.6M +$2.25M +1,182,537 +8%
SC
4
Sculptor Capital
New York
$24.1M -$6.4K -3,360 -0%
MCM
5
Mason Capital Management
New York
$23.4M +$5.99M +3,143,258 +37%
FTCM
6
Fir Tree Capital Management
New York
$19.5M +$6.72M +3,528,000 +57%
AC
7
Aristeia Capital
Connecticut
$13.2M -$658K -345,313 -5%
AAA
8
Alpine Associates Advisors
New Jersey
$10.9M -$857K -450,000 -8%
NRC
9
North Run Capital
Massachusetts
$9.97M -$1.54M -808,327 -14%
Allianz Asset Management
10
Allianz Asset Management
Germany
$9.58M -$125K -65,611 -1%
MFP
11
Michael F. Price
$8.13M – – –
AGC
12
Angelo Gordon & Co
New York
$6.98M – – –
YCMGA
13
York Capital Management Global Advisors
New York
$6.41M -$38.1K -20,000 -0.6%
COPPSERS
14
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$6.13M – – –
GCM
15
Gruss Capital Management
New York
$5.24M – – –
BHIA
16
Birch Hill Investment Advisors
Massachusetts
$3.68M -$209K -109,500 -6%
GF
17
Gabelli Funds
New York
$3.64M -$19K -10,000 -0.6%
TA
18
TRB Advisors
New York
$3.08M +$238K +125,000 +9%
SAM
19
Silverback Asset Management
North Carolina
$3.05M +$968K +508,238 +51%
SA
20
Smithwood Advisers
California
$3.03M – – –
Adage Capital Partners
21
Adage Capital Partners
Massachusetts
$2.84M – – –
NM
22
Newtyn Management
New York
$2.83M -$317K -166,546 -11%
PI
23
Putnam Investments
Massachusetts
$2.54M – – –
HCM
24
Highbridge Capital Management
New York
$2.52M -$190K -100,000 -7%
Bank of America
25
Bank of America
North Carolina
$2.5M +$666K +349,529 +39%
1
2 3 4 5

GCVRZ Hedge Fund Activity: Q3 2013 in Review

136 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q3 2013, worth a combined $338M — up 4.3% from $324M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of GCVRZ and 7 opened new positions — a net loss of 10 holders — while 35 trimmed existing stakes and 21 added.

The largest buyer was Fir Tree Capital Management, adding an estimated $6.72M. The largest seller was Taconic Capital Advisors, exiting entirely with an estimated $5.79M sold.

  • 136 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q3 2013, down from 146 in Q2 2013.
  • Funds reported $338M of Sanofi Contingent Value Rights stock for Q3 2013, up 4.3% quarter-over-quarter.
  • 7 funds opened new Sanofi Contingent Value Rights positions in Q3 2013 and 17 closed out, a net change of -10 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q3 2013 was Fir Tree Capital Management, an estimated $6.72M added.
  • The largest Sanofi Contingent Value Rights seller in Q3 2013 was Taconic Capital Advisors, an estimated $5.79M sold.

Based on aggregated 13F filings for Q3 2013.